- Home
- LXFR vs NPCE Comparison
LXFR vs NPCE Comparison
Compare LXFR & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXFR
- NPCE
- Stock Information
- Founded
- LXFR 1898
- NPCE 1997
- Country
- LXFR United States
- NPCE United States
- Employees
- LXFR N/A
- NPCE N/A
- Industry
- LXFR Major Chemicals
- NPCE Medical Specialities
- Sector
- LXFR Industrials
- NPCE Health Care
- Exchange
- LXFR Nasdaq
- NPCE Nasdaq
- Market Cap
- LXFR 335.4M
- NPCE 292.9M
- IPO Year
- LXFR 2012
- NPCE 2021
- Fundamental
- Price
- LXFR $13.42
- NPCE $9.15
- Analyst Decision
- LXFR
- NPCE Strong Buy
- Analyst Count
- LXFR 0
- NPCE 6
- Target Price
- LXFR N/A
- NPCE $16.67
- AVG Volume (30 Days)
- LXFR 135.6K
- NPCE 205.3K
- Earning Date
- LXFR 10-28-2025
- NPCE 08-12-2025
- Dividend Yield
- LXFR 3.87%
- NPCE N/A
- EPS Growth
- LXFR N/A
- NPCE N/A
- EPS
- LXFR 0.90
- NPCE N/A
- Revenue
- LXFR $403,800,000.00
- NPCE $88,570,000.00
- Revenue This Year
- LXFR $3.12
- NPCE $22.13
- Revenue Next Year
- LXFR $3.31
- NPCE $6.07
- P/E Ratio
- LXFR $13.74
- NPCE N/A
- Revenue Growth
- LXFR 5.60
- NPCE 23.32
- 52 Week Low
- LXFR $9.41
- NPCE $5.45
- 52 Week High
- LXFR $15.64
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- LXFR 64.00
- NPCE 51.74
- Support Level
- LXFR $12.32
- NPCE $8.61
- Resistance Level
- LXFR $13.86
- NPCE $8.99
- Average True Range (ATR)
- LXFR 0.45
- NPCE 0.53
- MACD
- LXFR 0.11
- NPCE 0.11
- Stochastic Oscillator
- LXFR 78.85
- NPCE 75.00
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.